celecoxib has been researched along with Cancer of Endometrium in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Compare postoperative pain scores following hysterectomy in patients receiving perioperative celecoxib versus postoperative ketorolac as part of a multimodal pain regimen." | 2.87 | Celecoxib versus ketorolac following robotic hysterectomy for the management of postoperative pain: An open-label randomized control trial. ( ElNaggar, AC; Tillmanns, TD; Ulm, MA, 2018) |
| "The underlying causes of endometrial cancer (EMC) are poorly understood, and treatment options for patients with advanced stages of the disease are limited." | 1.40 | Mammalian target of rapamycin complex 1 and cyclooxygenase 2 pathways cooperatively exacerbate endometrial cancer. ( Cappelletti, M; Daikoku, T; Dey, SK; Ellenson, LH; Hossain, MM; Terakawa, J; Yang, P; Yoshie, M, 2014) |
| "Celecoxib was the most effective anti-proliferative agent, and increased the G0/G1 phase proportion in the cell cycle after treatment more significantly than the other agents in all cell lines." | 1.32 | Comparison of the anti-proliferation and apoptosis-induction activities of sulindac, celecoxib, curcumin, and nifedipine in mismatch repair-deficient cell lines. ( Lin, YS; Tsao, PN; Wei, SC; Wong, JM; Wu, CH; Wu-Tsai, JJ, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ulm, MA | 1 |
| ElNaggar, AC | 1 |
| Tillmanns, TD | 1 |
| Daikoku, T | 1 |
| Terakawa, J | 1 |
| Hossain, MM | 1 |
| Yoshie, M | 1 |
| Cappelletti, M | 1 |
| Yang, P | 1 |
| Ellenson, LH | 1 |
| Dey, SK | 1 |
| Wei, SC | 1 |
| Lin, YS | 1 |
| Tsao, PN | 1 |
| Wu-Tsai, JJ | 1 |
| Wu, CH | 1 |
| Wong, JM | 1 |
1 trial available for celecoxib and Cancer of Endometrium
| Article | Year |
|---|---|
Celecoxib versus ketorolac following robotic hysterectomy for the management of postoperative pain: An open-label randomized control trial.
Topics: Activities of Daily Living; Administration, Intravenous; Administration, Oral; Adult; Aged; Analgesi | 2018 |
2 other studies available for celecoxib and Cancer of Endometrium
| Article | Year |
|---|---|
Mammalian target of rapamycin complex 1 and cyclooxygenase 2 pathways cooperatively exacerbate endometrial cancer.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Blotting, Western; Carcinoma; Celecoxib; Cell Line, | 2014 |
Comparison of the anti-proliferation and apoptosis-induction activities of sulindac, celecoxib, curcumin, and nifedipine in mismatch repair-deficient cell lines.
Topics: Antineoplastic Agents; Apoptosis; Celecoxib; Cell Cycle; Cell Line, Tumor; Chemoprevention; Colorect | 2004 |